FDA 21 CFR Part 11 Compliance vs. GMP Certification: What Is the Difference?
In corporate compliance management, FDA 21 CFR Part 11 and GMP (Good Manufacturing Practice) are often discussed together — but they are not the same kind of thing. GMP is a certification regime applied to a manufacturing operation. Part 11 is a regulation, not a certification. Confusing the two is one of the most common mistakes companies make when preparing for the US market.
The core difference: a regulation vs a certification
21 CFR Part 11 is a US federal regulation. It sets out what electronic records and electronic signatures must satisfy when a predicate rule requires a record to be maintained or submitted, and the organisation relies on the electronic version. It is not awarded by a body and there is no such thing as a blanket "Part 11 certificate" for a product.
GMP is a certification standard applied to a manufacturing operation — its facilities, equipment, personnel, processes and quality-management system.
That single difference reshapes every other dimension of comparison.
Dimension-by-dimension comparison
What is assessed
- Part 11: the electronic record and signature chain — audit trails, signature manifestation, signature-to-record binding, identity and access controls, retention and retrieval.
- GMP: the entire production process — facilities, equipment, personnel, manufacturing processes and the quality-management system.
Who carries the responsibility
- Part 11: the regulated organisation owns intended use, procedures, validation, training, access governance and record retention. A vendor supplies product controls and documentation, but cannot transfer compliance.
- GMP: the manufacturing company itself.
What "passing" looks like
- Part 11: no certificate is issued. An organisation demonstrates compliance through a documented scope decision, a validated system, controlled procedures and retained evidence — reviewed during an FDA inspection.
- GMP: successful inspection leads to a GMP certificate or equivalent authorisation.
Which standards apply
- Part 11: 21 CFR Part 11 itself, including uniqueness of signatures, at least two distinct identification components for non-biometric signatures, and controls for closed and open systems.
- GMP: national or regional GMP standards (for example, EU GMP including Annex 11 for computerised systems, and US CGMP).
Typical preparation path
- Part 11: document the record inventory and scope decision, define intended use and system boundaries, configure identity and access controls, design the evidence package, validate against risk, then operate under controlled procedures.
- GMP: internal audit and remediation, documentation, application, technical review and on-site inspection, rectification of non-conformities, and certification.
Where the two meet
GMP and Part 11 are not alternatives — they overlap. Where a GMP operation keeps records electronically, EU GMP Annex 11 and Part 11 expectations both apply to the same computerised systems. A pharmaceutical manufacturer that is GMP-certified does not thereby satisfy Part 11: the electronic-record and signature controls are assessed separately, and a software purchase alone does not close the gap.
Market background
As international e-signature providers such as Adobe Sign have scaled back in the Chinese market, eSign.AI has received a growing number of enquiries involving FDA and GxP compliance. The demand is for e-signature solutions that stand up to international review — and for a clear understanding of where the vendor's responsibility ends and the customer's begins.
How eSign.AI helps
eSign.AI provides electronic-signature and evidence capabilities that can be configured as part of a regulated process: signing meaning and manifestation, configurable signer verification and account controls, audit evidence, and API or workflow integration. Using eSign.AI does not by itself make an organisation Part 11 compliant — compliance depends on the customer's intended use, procedures, validation and governance. eSign.AI completed a SOC 2 Type II attestation in 2025, an independent report useful in vendor due diligence but not a substitute for the customer's own validation.
Conclusion
Part 11 and GMP play different roles:
- Part 11 is a regulation governing the compliance of electronic record and signature systems — demonstrated, not certified.
- GMP is a certification governing the standardisation of the whole production process.
Companies entering the US market should plan for both, and should be wary of vendors that offer a "Part 11 certificate" as if it were a product badge.
Further reading: FDA 21 CFR Part 11 Electronic Signatures: A Practical Guide · What Is FDA 21 CFR Part 11?